MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, D. B.
Right arrow Articles by Hess, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, D. B.
Right arrow Articles by Hess, E. J.

Vol. 55, Issue 1, 23-31, January 1999

L-Type Calcium Channels Contribute to the Tottering Mouse Dystonic Episodes

Daniel B. Campbell and Ellen J. Hess

Department of Neuroscience and Anatomy, Pennsylvania State University College of Medicine, Hershey, Pennsylvania

Tottering mice inherit a recessive mutation of the calcium channel alpha 1A subunit that causes ataxia, polyspike discharges, and intermittent dystonic episodes. The calcium channel alpha 1A subunit gene encodes the pore-forming protein of P/Q-type voltage-dependent calcium channels and is predominantly expressed in cerebellar granule and Purkinje neurons with moderate expression in hippocampus and inferior colliculus. Because calcium misregulation likely underlies the tottering mouse phenotype, calcium channel blockers were tested for their ability to block the motor episodes. Pharmacologic agents that specifically block L-type voltage-dependent calcium channels, but not P/Q-type calcium channels, prevented the inducible dystonia of tottering mutant mice. Specifically, the dihydropyridines nimodipine, nifedipine, and nitrendipine, the benzothiazepine diltiazem, and the phenylalkylamine verapamil all prevented restraint-induced tottering mouse motor episodes. Conversely, the L-type calcium channel agonist Bay K8644 induced stereotypic tottering mouse dystonic at concentrations significantly below those required to induce seizures in control mice. In situ hybridization demonstrated that L-type calcium channel alpha 1C subunit mRNA expression was up-regulated in the Purkinje cells of tottering mice. Radioligand binding with [3H]nitrendipine also revealed a significant increase in the density of L-type calcium channels in tottering mouse cerebellum. These data suggest that although a P/Q-type calcium channel mutation is the primary defect in tottering mice, L-type calcium channels may contribute to the generation of the intermittent dystonia observed in these mice. The susceptibility of L-type calcium channels to voltage-dependent facilitation may promote this abnormal motor phenotype.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. E. Pardo, R. K. Hajela, and W. D. Atchison
Acetylcholine Release at Neuromuscular Junctions of Adult Tottering Mice Is Controlled by N-(Cav2.2) and R-Type (Cav2.3) but Not L-Type (Cav1.2) Ca2+ Channels
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1009 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S.-N. Yang and P.-O. Berggren
The Role of Voltage-Gated Calcium Channels in Pancreatic {beta}-Cell Physiology and Pathophysiology
Endocr. Rev., October 1, 2006; 27(6): 621 - 676.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Imbrici, S. L. Jaffe, L. H. Eunson, N. P. Davies, C. Herd, R. Robertson, D. M. Kullmann, and M. G. Hanna
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia
Brain, December 1, 2004; 127(12): 2682 - 2692.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhang, A. P. Vilaythong, D. Yoshor, and J. L. Noebels
Elevated Thalamic Low-Voltage-Activated Currents Precede the Onset of Absence Epilepsy in the SNAP25-Deficient Mouse Mutant Coloboma
J. Neurosci., June 2, 2004; 24(22): 5239 - 5248.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Song, D. Kim, S. Choi, M. Sun, Y. Kim, and H.-S. Shin
Role of the {alpha}1G T-Type Calcium Channel in Spontaneous Absence Seizures in Mutant Mice
J. Neurosci., June 2, 2004; 24(22): 5249 - 5257.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Xu, A. Welling, S. Paparisto, F. Hofmann, and N. Klugbauer
Enhanced Expression of L-type Cav1.3 Calcium Channels in Murine Embryonic Hearts from Cav1.2-deficient Mice
J. Biol. Chem., October 17, 2003; 278(42): 40837 - 40841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. T. Bello, K. L. Sweigart, J. M. Lakoski, R. Norgren, and A. Hajnal
Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1260 - R1268.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Racz, A. Bilkei-Gorzo, Z. E. Toth, K. Michel, M. Palkovits, and A. Zimmer
A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking
J. Neurosci., March 15, 2003; 23(6): 2453 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Z. Khan and H. A. Jinnah
Paroxysmal Dyskinesias in the Lethargic Mouse Mutant
J. Neurosci., September 15, 2002; 22(18): 8193 - 8200.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. E. Pizoli, H. A. Jinnah, M. L. Billingsley, and E. J. Hess
Abnormal Cerebellar Signaling Induces Dystonia in Mice
J. Neurosci., September 1, 2002; 22(17): 7825 - 7833.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhang, M. Mori, D. L. Burgess, and J. L. Noebels
Mutations in High-Voltage-Activated Calcium Channel Genes Stimulate Low-Voltage-Activated Currents in Mouse Thalamic Relay Neurons
J. Neurosci., August 1, 2002; 22(15): 6362 - 6371.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. L. Eagleson, L. D. Fairfull, S. R. J. Salton, and P. Levitt
Regional Differences in Neurotrophin Availability Regulate Selective Expression of VGF in the Developing Limbic Cortex
J. Neurosci., December 1, 2001; 21(23): 9315 - 9324.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R. Felix
Channelopathies: ion channel defects linked to heritable clinical disorders
J. Med. Genet., October 1, 2000; 37(10): 729 - 740.
[Abstract] [Full Text]


Home page
BrainHome page
J. J. Plomp, M. N. Vergouwe, A. M. Van den Maagdenberg, M. D. Ferrari, R. R. Frants, and P. C. Molenaar
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering {alpha}1A Ca2+ channel mutation
Brain, March 1, 2000; 123(3): 463 - 471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jun, E. S. Piedras-Renteria, S. M. Smith, D. B. Wheeler, S. B. Lee, T. G. Lee, H. Chin, M. E. Adams, R. H. Scheller, R. W. Tsien, et al.
Ablation of P/Q-type Ca2+ channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the alpha 1A-subunit
PNAS, December 21, 1999; 96(26): 15245 - 15250.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. F. Fletcher and WayneN. Frankel
Ataxic mouse mutantsand molecular mechanisms of absence epilepsy
Hum. Mol. Genet., September 1, 1999; 8(10): 1907 - 1912.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics